[go: up one dir, main page]

ES2148681T3 - Compuestos de benzotiofeno de uso farmaceutico. - Google Patents

Compuestos de benzotiofeno de uso farmaceutico.

Info

Publication number
ES2148681T3
ES2148681T3 ES96301534T ES96301534T ES2148681T3 ES 2148681 T3 ES2148681 T3 ES 2148681T3 ES 96301534 T ES96301534 T ES 96301534T ES 96301534 T ES96301534 T ES 96301534T ES 2148681 T3 ES2148681 T3 ES 2148681T3
Authority
ES
Spain
Prior art keywords
alkyl
rdurule
aryl
compounds
progestin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96301534T
Other languages
English (en)
Inventor
Henry Uhlman Bryant
Jeffrey Alan Dodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2148681T3 publication Critical patent/ES2148681T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN COMPUESTO DE FORMULA I DONDE R{SUB,1} ES H, OH, HALO, OCO(C{SUB,1}-C{SUB,6} ALQUILO), OCO(ARILO), OSO{SUB,2} (C{SUB,4}-C{SUB,6} ALQUILO), OCOO (C{SUB,1}-C{SUB,6} ALQUILO),OCOO(ARILO), OCONH(C{SUB,1}-C{SUB,6} ALQUILO), O OCON(C{SUB,1}-C{SUB,6}ALQUILO){SUB,2}; R{SUB,2} ES ARILO, C{SUB,1}-C{SUB,6} ALQUILO, C{SUB,3}-C{SUB,6} CICLOALQUILO, O 4-CICLOHEXANOL; R{SUB,3} ES O(CH{SUB,2}){SUB,2} O O(CH{SUB,2}){SUB,3}; R{SUB,4} Y R{SUB,5} SON OPCIONALMENTE CO(CH{SUB,2}){SUB,3}, CO(CH{SUB,2}){SUB,4}, C{SUB,1}-C{SUB,6} ALQUILO, O R{SUB,4} Y R{SUB,5} SE COMBINA PARA FORMAR, CON EL NITROGENO PARA EL QUE ELLOS ESTAN LIGADOS, PIPERIDINA, MORFOLINA, PIRROLIDINA, 3METILPIROLLIDINA, 3,3-DIMETILPIROLLIDINA, 3,4-DIMETILPIROLLIDINA, AZEPINA O PIPECOLINA; R{SUB,6} ES C=CH{SUB,2}, CH(C{SUB,1}-C{SUB,5}ALQUILO), CH(C{SUB,2}-C{SUB,5} ALQUENILO), C=CH(C{SUB,1}-C{SUB,5} ALQUILO, CH(ARILO),C(OH)(C{SUB,1}C{SUB,5}ALQUILO), C(OH)(C{SUB,2}-C{SUB,5}ALQUENILO), C(OH)ARILO; Y SALES DE LAS MISMA ACEPTABLES FARMACEUTICAMENTE. LA PRESENTE INVENCION PROPORCIONA POSTERIORMENTE COMPOSICIONES FARMACEUTICAS CONTENIENDO COMPUESTOS DE LA FORMULA I, OPCIONALMENTE CONTENIENDO ESTROGENO O PROGESTINA, Y EL USO DE DICHOS COMPUESTOS SOLOS, O EN COMBINACION CON ESTROGENO O PROGESTINA, PARA ALIVIAR LOS SINTOMAS DEL SINDROME POSTMENOPAUSICO, PARTICULARMENTE OSTEOPOROSIS, CONDICIONES CARDIOVASCULARES PATOLOGICAMENTE RELACIONADAS Y CANCER DEPENDIENTE DE ESTROGENO. COMO SE USA AQUI , EL TERMINO "PROGESTINA" INCLUYE COMPUESTOS QUE CONTIENEN ACTIVIDAD PROGESTINACIONAL, COMO POR EJEMPLO, PROGESTERONA, NORETILNODRELO, NONGESTROL, ACETATO MEGESTROL, NORETINDRONE. LOS COMPUESTOS DE LA PRESENTE INVENCION TAMBIEN SON UTILES PARA LA INHIBICION DE ENFERMEDADES DE LAS FIBRAS UTERINAS Y ENDOMETRIOSIS EN MUJERES Y PROLIFERACION DE CELULAS MUSCULARES SUAVIZANTES DE LA AORTA, PARTICULARMENTE RESTENOSIS EN HUMANOS.
ES96301534T 1995-03-10 1996-03-06 Compuestos de benzotiofeno de uso farmaceutico. Expired - Lifetime ES2148681T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/402,415 US6395755B1 (en) 1995-03-10 1995-03-10 Benzothiophene pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ES2148681T3 true ES2148681T3 (es) 2000-10-16

Family

ID=23591799

Family Applications (2)

Application Number Title Priority Date Filing Date
ES99202800T Expired - Lifetime ES2205702T3 (es) 1995-03-10 1996-03-06 Compuesto farmaceuticos de benzotiofeno.
ES96301534T Expired - Lifetime ES2148681T3 (es) 1995-03-10 1996-03-06 Compuestos de benzotiofeno de uso farmaceutico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES99202800T Expired - Lifetime ES2205702T3 (es) 1995-03-10 1996-03-06 Compuesto farmaceuticos de benzotiofeno.

Country Status (16)

Country Link
US (1) US6395755B1 (es)
EP (2) EP0731100B1 (es)
JP (1) JPH11501930A (es)
AT (2) ATE195519T1 (es)
AU (1) AU697502B2 (es)
BR (1) BR9607775A (es)
CA (1) CA2214261A1 (es)
DE (2) DE69609748T2 (es)
DK (1) DK0731100T3 (es)
ES (2) ES2205702T3 (es)
GR (1) GR3034762T3 (es)
IL (1) IL117398A (es)
PT (1) PT731100E (es)
SI (1) SI0731100T1 (es)
WO (1) WO1996028155A1 (es)
ZA (1) ZA961883B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432982B1 (en) * 1996-02-21 2002-08-13 Eli Lilly And Company Benzothiophenes, and formulations and methods using same
EP0801066A1 (en) * 1996-03-12 1997-10-15 Eli Lilly And Company Heterocyclic substituted benzothiophenes and pharmaceutical compositions
CA2214072C (en) * 1996-08-29 2006-11-14 Eli Lilly And Company Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
CA2214196A1 (en) * 1996-09-26 1998-03-26 Eli Lilly And Company Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
CA2216592C (en) * 1996-10-24 2006-07-18 Brian Stephen Muehl Benzothiophene compounds, intermediates, compositions, and methods
US7056931B2 (en) 2001-05-22 2006-06-06 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
ES2236536T3 (es) 2001-05-22 2005-07-16 Eli Lilly And Company Derivados tetrahidroquinolino para la inhibicion de enfermedades asociadas con la privacion de estrogenos o con una respuesta fisiologica aberrante a estrogenos endogenos.
IL158871A0 (en) 2001-07-31 2004-05-12 Pfizer Prod Inc Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
ATE448215T1 (de) * 2004-01-22 2009-11-15 Lilly Co Eli Selektive östrogen-rezeptor-modulatoren
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1300575B (de) * 1965-05-21 1969-08-07 Bristol Myers Co Benzo[b]thiophene
US3947470A (en) 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
IT1154888B (it) * 1980-11-12 1987-01-21 Menarini Sas Derivati del benzofurano 2-sostituiti e relativi metodi di preparazione
IL65379A0 (en) * 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
IL65404A0 (en) * 1981-04-03 1982-07-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4851554A (en) 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
AU2543388A (en) * 1987-09-30 1989-04-18 University Of Tennessee Research Corporation, The Certain 3-substituted 2-alkyl benzothiophene derivatives
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5482949A (en) 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5523309A (en) * 1995-03-10 1996-06-04 Eli Lilly And Company Benzofuran pharmaceutical compounds

Also Published As

Publication number Publication date
ZA961883B (en) 1997-09-08
ES2205702T3 (es) 2004-05-01
JPH11501930A (ja) 1999-02-16
US6395755B1 (en) 2002-05-28
DE69629500T2 (de) 2004-07-01
ATE195519T1 (de) 2000-09-15
IL117398A (en) 2000-11-21
DK0731100T3 (da) 2000-09-18
GR3034762T3 (en) 2001-02-28
AU5304896A (en) 1996-10-02
DE69609748D1 (de) 2000-09-21
EP0953568A1 (en) 1999-11-03
PT731100E (pt) 2001-01-31
EP0731100A1 (en) 1996-09-11
DE69609748T2 (de) 2001-04-12
IL117398A0 (en) 1996-07-23
AU697502B2 (en) 1998-10-08
DE69629500D1 (de) 2003-09-18
ATE247100T1 (de) 2003-08-15
WO1996028155A1 (en) 1996-09-19
SI0731100T1 (en) 2001-02-28
EP0731100B1 (en) 2000-08-16
MX9706737A (es) 1997-11-29
CA2214261A1 (en) 1996-09-19
EP0953568B1 (en) 2003-08-13
BR9607775A (pt) 1998-07-07

Similar Documents

Publication Publication Date Title
ZA957857B (en) Naphtyl compounds intermediates processes compositions and methods
CA2228997A1 (en) Benzothiophene compounds
LV12618A (en) Use of sulphamate derivatives as steroid sulphatase inhibitors
ES2148681T3 (es) Compuestos de benzotiofeno de uso farmaceutico.
IE46092L (en) Esters of the androstane and oestrane series
PL324816A1 (en) Naphtylic and dihydronaphtylic intermediatew compounds, compounds, agents and associated compounds
AR007012A1 (es) Compuestos de 2-fenil-3-benzoil-benzotiofenos, composiciones farmaceuticas que los contienen y el uso de dichos compuestos para el tratamiento del sindrome postmenopausico, inhibicion del cancer estrogenodependiente, entre otras afecciones patologicas
ATE253567T1 (de) Benzofuranverbindungen, präparate und verfahren
NZ334184A (en) Naphthyl compounds, intermediates, compositions for the prevention of bone loss or bone resorption and lower cholesterol
MX9706741A (es) Compuestos farmaceuticos novedosos de naftilo.
IE901314L (en) 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines
GB1033920A (en) Novel derivatives of triphenylethanols
DE60031557D1 (de) Steroide, ihre herstellung , pharmazeutische zusammensetzungen mit ihnen und verwendungen dieser verbindungen
MX9706738A (es) Nuevos compuestos farmaceuticos de benzofurano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 731100

Country of ref document: ES